Bright Green Corporation
General ticker "BGXX" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $8.9M (TTM average)
Bright Green Corporation does not follow the US Stock Market performance with the rate: -3.9%.
Estimated limits based on current volatility of 0.0%: low 0.04$, high 0.04$
Factors to consider:
- Total employees count: 23 as of 2022
- Top business risk factors: Negative cash flow, Labor/talent shortage/retention, Pandemic risks, Internal control weaknesses, Expanding product/sales risks
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [0.06$, 0.26$]
- 2024-12-30 to 2025-12-30 estimated range: [0.04$, 0.16$]
Short-term BGXX quotes
Long-term BGXX plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.40MM |
| Operating Expenses | $2.49MM | $27.31MM | $9.29MM |
| Operating Income | $-2.49MM | $-27.31MM | $-8.89MM |
| Non-Operating Income | $0.00MM | $-0.21MM | $-4.02MM |
| Income(Loss) | $-2.49MM | $-27.53MM | $-12.91MM |
| Taxes | $0.00MM | $0.14MM | $0.22MM |
| Profit(Loss)* | $-2.49MM | $-27.24MM | $-13.13MM |
| Stockholders Equity | $8.22MM | $11.58MM | $10.96MM |
| Assets | $8.78MM | $22.79MM | $17.40MM |
| Operating Cash Flow | $-1.66MM | $-2.27MM | $-2.46MM |
| Capital expenditure | $0.30MM | $11.68MM | $2.53MM |
| Investing Cash Flow | $-0.30MM | $-14.37MM | $-2.53MM |
| Financing Cash Flow | $3.14MM | $15.77MM | $4.58MM |
| Earnings Per Share** | $-0.02 | $-0.17 | $-0.07 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.